Yijia Huang

Yijia Huang

Auto-generated profile, based on publicly available information

Yijia Huang

School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University , Nangchang , China

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Open Medicine
Verified
Journal Article
Open access
PDF file
PZPengfei Zhang
Pengfei Zhang
YHYijia Huang
Yijia Huang
HLHaoying Li
Haoying Li
CZCan Zhang
Can Zhang
ZCZhiren Chen
Zhiren Chen
Objectives: To investigate the causal relationship between genetically predicted levels of five circulating cytokines – CXCL11, IL-2, IL-4, leukemia inhibitory factor (LIF), and neurotrophin-3 (NT-3) – and the risk of hypertensive encephalopathy using a two-sample Mendelian randomization (MR) approach. Methods: Single nucleotide polymorphisms (SNPs) strongly associated with each cytokine (p < 5 × 10 −8 ) were selected from publicly available GWAS data. Summary statistics for HE were obtained from the FinnGen biobank (endpoint: I9_HYPERTENC). MR analyses were conducted using inverse-variance weighted (IVW), MR-Egger, weighted median, and weighted mode methods. Sensitivity analyses included heterogeneity testing, MR-Egger intercept assessment, and leave-one-out analysis. Results: Genetically higher levels of IL-2 (OR=0.35, 95 % CI: 0.13–0.99, p = 0.043), IL-4 (OR=0.50, 95 % CI: 0.30–0.85, p = 0.010), and NT-3 (OR=0.46, 95 % CI: 0.28–0.75, p = 0.0038) were significantly associated with lower risk of HE. CXCL11 showed a significant positive association with HE risk (OR=2.79, 95 % CI: 1.26–6.20, p = 0.028). LIF displayed a non-significant trend toward protection (OR=0.43, p = 0.060). Results were consistent across sensitivity analyses with no evidence of pleiotropy or heterogeneity. Conclusions: This Mendelian randomization study provides evidence that genetically determined levels of IL-2, IL-4, and NT-3 are protective against hypertensive encephalopathy, while CXCL11 is a risk factor. These cytokines may serve as potential biomarkers or therapeutic targets for HE.